Showing results (1-10 of 744) with videos related to
Sort By:
Pageof 75
Current Pharmaceutical Design|May 29, 2003
Cytokine and anti-cytokine therapies for inflammatory bowel diseaseHaruhiko Ogata, Toshifumi HibiCurrent Opinion in Gastroenterology|July 16, 2008
Innate immunity in inflammatory bowel disease: state of the artTadakazu Hisamatsu, Haruhiko Ogata, Toshifumi HibiParasitology International|September 3, 2013
Endoscopic imaging of parasites in the human digestive tractNaoki Hosoe, Haruhiko Ogata, Toshifumi HibiJournal of Gastroenterology|April 18, 2003
Introduction and overview: recent advances in the immunotherapy of inflammatory bowel diseaseToshifumi Hibi, Nagamu Inoue, Haruhiko Ogata, et al.Nihon Rinsho. Japanese Journal of Clinical Medicine|October 12, 2007
[Expectation of video capsule endoscopy for diagnosis of NSAID induced enteropathy]Hiroyuki Imaeda, Haruhiko Ogata, Yasushi Iwao, et al.Intestinal Research|May 11, 2018
Comparison of efficacy of once daily multimatrix mesalazine 2.4 g/day and 4.8 g/day with other 5-aminosalicylic acid preparation in active ulcerative colitis: a randomized, double-blind studyHaruhiko Ogata, Tadashi Yokoyama, Seiichi Mizushima, et al.Intestinal Research|July 4, 2017
Comparison of efficacy of multimatrix mesalazine 4.8 g/day once-daily with other high-dose mesalazine in active ulcerative colitis: a randomized, double-blind studyHaruhiko Ogata, Nobuo Aoyama, Seiichi Mizushima, et al.Intestinal Research|November 9, 2020
Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational studyHaruhiko Ogata, Takashi Hagiwara, Takeshi Kawaberi, et al.Journal of Gastroenterology|July 16, 2009
Coping strategy when patients with quiescent Crohn's disease recognize that their conditions are worseningMakoto Tanaka, Yasushi Iwao, Susumu Okamoto, et al.Intestinal Research|July 4, 2017
Comparison of efficacies of once-daily dose multimatrix mesalazine and multiple-dose mesalazine for the maintenance of remission in ulcerative colitis: a randomized, double-blind studyHaruhiko Ogata, Akihiro Ohori, Haruo Nishino, et al.Pageof 75